These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 14477991)

  • 1. Bradykinin: a vasodepressor polypeptide.
    NAHUM LH
    Conn Med; 1962 Feb; 26():124-5. PubMed ID: 14477991
    [No Abstract]   [Full Text] [Related]  

  • 2. Anaphylactic shock in dogs. Role of fibrinolysin and vasoactive polypeptide systems.
    BACK N; MUNSON AE; GUTH PS
    JAMA; 1963 Jan; 183():260-3. PubMed ID: 13965954
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapy with kallikrein and protease inhibitors.
    FORELL MM
    Ann N Y Acad Sci; 1963 Feb; 104():368-75. PubMed ID: 13958716
    [No Abstract]   [Full Text] [Related]  

  • 4. Kininogenase activity of prostate-derived human glandular kallikrein (hK2) purified from seminal fluid.
    Charlesworth MC; Young CY; Miller VM; Tindall DJ
    J Androl; 1999; 20(2):220-9. PubMed ID: 10232657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [On bradykinin, kallidin, and various analogous kinds of biologically active polypeptides].
    MORIYA H
    Tanpakushitsu Kakusan Koso; 1962 Jun; 7():382-6. PubMed ID: 14476151
    [No Abstract]   [Full Text] [Related]  

  • 6. [STRUCTURE AND FUNCTION OF THE BIOLOGICALLY ACTIVE PEPTIDES: BRADYKININ, KALLIDIN, ANGIOTENSIN AND SUBSTANCE P].
    MICHAUD J
    Presse Med (1893); 1964 Oct; 72():2693-8. PubMed ID: 14226744
    [No Abstract]   [Full Text] [Related]  

  • 7. [PLASMA-KININS].
    WERLE E
    Munch Med Wochenschr; 1963 Dec; 105():2486-93. PubMed ID: 14132754
    [No Abstract]   [Full Text] [Related]  

  • 8. Bradykinin activity of some synthetic peptides with only slight structural resemblance to natural bradykinin.
    TRITSCH GL; WOOLLEY DW
    Nature; 1960 Apr; 186():76-7. PubMed ID: 13839411
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis and biological activity of peptides related to bradykinin.
    BOISSONNAS RA; GUTTMANN S; JAQUENOUD PA; KONZETT H; STUERMER E
    Experientia; 1960 Jul; 16():326. PubMed ID: 13802238
    [No Abstract]   [Full Text] [Related]  

  • 10. [Kallikrein-kinin system and active peptides in the blood].
    Suzuki T; Nagasawa S
    Tanpakushitsu Kakusan Koso; 1967 Mar; 12(3):201-10. PubMed ID: 4864449
    [No Abstract]   [Full Text] [Related]  

  • 11. Antagonistic effect of kallikrein against bradykinin.
    Ercan ZS; Türker RK; Torunoglu M
    Arzneimittelforschung; 1978; 28(10):1712-4. PubMed ID: 582675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biochemical remarks on therapy with kallikrein and kallikrein inactivator].
    WERLE E
    Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1963; 303():5-10. PubMed ID: 14000005
    [No Abstract]   [Full Text] [Related]  

  • 13. DETERMINATION OF BRADYKININ AND KALLIKREIN AS DIAGNOSTIC METHODS IN CARDIOVASCULAR DISEASE.
    OATES JA
    Listing Res Cardiovasc Field; 1964; 10():259-60. PubMed ID: 24547441
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypertensive effects of bradykinin and anephrotensin in normal and nephrectomized animals.
    CROXATTO H; BELMAR J; PEREDA T; LABARCA E
    Acta Physiol Lat Am; 1962; 12():19-21. PubMed ID: 13882445
    [No Abstract]   [Full Text] [Related]  

  • 15. Bradykinin.
    LEWIS GP
    Nature; 1961 Nov; 192():596-9. PubMed ID: 14464868
    [No Abstract]   [Full Text] [Related]  

  • 16. Bradykinin; mechanism of its release by trypsin and kallikrein.
    ROCHA M; SILVA
    Arch Int Pharmacodyn Ther; 1951 Dec; 88(3):271-82. PubMed ID: 14934358
    [No Abstract]   [Full Text] [Related]  

  • 17. ENDOGENEOUS MECHANISMS IN INCREASED VASCULAR PERMEABILITY IN INFLAMMATION.
    HAYASHI H
    Acta Pathol Jpn; 1963 Oct; 13():213-5. PubMed ID: 14195178
    [No Abstract]   [Full Text] [Related]  

  • 18. S(1)' and S(2)' subsite specificities of human plasma kallikrein and tissue kallikrein 1 for the hydrolysis of peptides derived from the bradykinin domain of human kininogen.
    Lima AR; Alves FM; Angelo PF; Andrade D; Blaber SI; Blaber M; Juliano L; Juliano MA
    Biol Chem; 2008 Dec; 389(12):1487-94. PubMed ID: 18844446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of kallikrein-kininogen system in insulin-stimulated glucose transport after muscle contractions.
    Dumke CL; Kim J; Arias EB; Cartee GD
    J Appl Physiol (1985); 2002 Feb; 92(2):657-64. PubMed ID: 11796678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aliskiren increases bradykinin and tissue kallikrein mRNA levels in the heart.
    Campbell DJ; Zhang Y; Kelly DJ; Gilbert RE; McCarthy DJ; Shi W; Smyth GK
    Clin Exp Pharmacol Physiol; 2011 Sep; 38(9):623-31. PubMed ID: 21736602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.